Adagene, Inc. (ADAG)
3.91
+0.06
(+1.56%)
USD |
NASDAQ |
Aug 27, 16:00
3.91
0.00 (0.00%)
After-Hours: 16:38
Adagene Market Cap : 262.53M for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 258.50M |
| August 25, 2026 | 256.49M |
| August 24, 2026 | 261.86M |
| August 21, 2026 | 269.92M |
| August 20, 2026 | 274.62M |
| August 19, 2026 | 276.63M |
| August 18, 2026 | 271.93M |
| August 17, 2026 | 257.16M |
| August 14, 2026 | 248.43M |
| August 13, 2026 | 249.77M |
| August 12, 2026 | 251.79M |
| August 11, 2026 | 261.19M |
| August 10, 2026 | 273.27M |
| August 07, 2026 | 194.75M |
| August 06, 2026 | 196.18M |
| August 05, 2026 | 200.44M |
| August 04, 2026 | 172.48M |
| August 03, 2026 | 172.01M |
| July 31, 2026 | 177.70M |
| July 30, 2026 | 176.75M |
| July 29, 2026 | 176.27M |
| July 28, 2026 | 176.75M |
| July 27, 2026 | 167.27M |
| July 24, 2026 | 151.63M |
| July 23, 2026 | 159.69M |
| Date | Value |
|---|---|
| July 22, 2026 | 169.64M |
| July 21, 2026 | 174.38M |
| July 20, 2026 | 171.54M |
| July 17, 2026 | 170.11M |
| July 16, 2026 | 169.64M |
| July 15, 2026 | 173.91M |
| July 14, 2026 | 171.06M |
| July 13, 2026 | 181.01M |
| July 10, 2026 | 186.70M |
| July 09, 2026 | 182.43M |
| July 08, 2026 | 181.49M |
| July 07, 2026 | 186.23M |
| July 06, 2026 | 186.23M |
| July 02, 2026 | 211.81M |
| July 01, 2026 | 226.50M |
| June 30, 2026 | 199.02M |
| June 29, 2026 | 200.44M |
| June 26, 2026 | 198.55M |
| June 25, 2026 | 195.23M |
| June 24, 2026 | 201.39M |
| June 23, 2026 | 188.59M |
| June 22, 2026 | 181.96M |
| June 18, 2026 | 186.70M |
| June 17, 2026 | 167.27M |
| June 16, 2026 | 166.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascletis Pharma, Inc. | 1.286B |
| CStone Pharmaceuticals Co. Ltd. | 1.032B |
| RemeGen Co., Ltd. | 5.714B |
| InnoCare Pharma Ltd. | 2.735B |
| JW (Cayman) Therapeutics Co. Ltd. | 82.03M |
Market Cap Related Metrics
| PS Ratio | 21.83 |
| Price | 3.91 |
| Earnings Yield | -9.65% |